Literature DB >> 2657579

Expression, methylation and chromatin structure of the p53 gene in untransformed and human T-cell leukemia virus type I-transformed human T-lymphocytes.

M Lübbert1, C W Miller, J Kahan, H P Koeffler.   

Abstract

p53 is a nuclear protein associated with cellular transformation and normal cellular proliferation. Some transformed cells have been found to have one or several quantitative or qualitative abnormalities of p53. We studied expression, kinetics, phosphorylation, DNA methylation and chromatin structure of p53 in resting and proliferating untransformed T-lymphocytes and in human T-cell leukemia virus type I transformed T-lymphocytes from the same individuals. p53 expression is indistinguishable in transformed compared to untransformed proliferating T-lymphocytes by: (1) p53 mRNA levels, (2) rate of synthesis and stability of p53 protein, (3) change in protein stability after exposure to an inhibitor of protein synthesis, (4) presence of phosphorylation of the p53 protein. Resting T-lymphocytes from these same individuals did not express p53. No difference in DNA methylation and chromatin structure of the p53 gene was observed in either resting or proliferating untransformed, or virally transformed T-lymphocytes. The gene was fully methylated and resistant to DNAase I over its entire coding region but was demethylated and contained DNAase I hypersensitive sites in a distinct region 5' of the site of initiation of transcription.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2657579

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  7 in total

1.  Compilation of vertebrate-encoded transcription factors.

Authors:  S Faisst; S Meyer
Journal:  Nucleic Acids Res       Date:  1992-01-11       Impact factor: 16.971

2.  Negative growth regulation in a glioblastoma tumor cell line that conditionally expresses human wild-type p53.

Authors:  W E Mercer; M T Shields; M Amin; G J Sauve; E Appella; J W Romano; S J Ullrich
Journal:  Proc Natl Acad Sci U S A       Date:  1990-08       Impact factor: 11.205

Review 3.  Nucleolar control of p53: a cellular Achilles' heel and a target for cancer therapy.

Authors:  Nikolina Vlatković; Mark T Boyd; Carlos P Rubbi
Journal:  Cell Mol Life Sci       Date:  2013-05-18       Impact factor: 9.261

Review 4.  P-glycoprotein expression and regulation. Age-related changes and potential effects on drug therapy.

Authors:  S Gupta
Journal:  Drugs Aging       Date:  1995-07       Impact factor: 3.923

5.  Induction of the WAF1/CIP1 protein and apoptosis in human T-cell leukemia virus type I-transformed lymphocytes after treatment with adriamycin by using a p53-independent pathway.

Authors:  R B Gartenhaus; P Wang; P Hoffmann
Journal:  Proc Natl Acad Sci U S A       Date:  1996-01-09       Impact factor: 11.205

Review 6.  Control of G1 arrest after DNA damage.

Authors:  M B Kastan; S J Kuerbitz
Journal:  Environ Health Perspect       Date:  1993-12       Impact factor: 9.031

7.  Aberrant expression of the p53 tumor suppressor gene in adult T-cell leukemia and HTLV-I-infected cells.

Authors:  K Yamato; T Oka; M Hiroi; Y Iwahara; S Sugito; N Tsuchida; I Miyoshi
Journal:  Jpn J Cancer Res       Date:  1993-01
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.